Prescription drug · UNAPPROVED DRUG OTHER
Vitrexate FE NDC 59088-168
ferrous fumarate, folic acid · Chromium nicotinate 35 ug/1 + 17 more ingredients · Tablet · Oral · PureTek Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 59088-168-54 | 59088016854 | 30 TABLET in 1 BOTTLE, PLASTIC (59088-168-54)Marketed from Nov 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vitrexate FE
- Generic name (nonproprietary)
- ferrous fumarate, folic acid
- Active ingredients
- Chromium nicotinate — 35 ug/1Folic acid — 1000 ug/1Vitamin a acetate — 1500 ug/1Riboflavin — 3.4 mg/1Niacinamide — 20 mg/1Pyridoxine hydrochloride — 20 mg/1Cyanocobalamin — 8 ug/1Calcium carbonate — 200 mg/1Ascorbic acid — 120 mg/1Thiamine mononitrate — 3 mg/1Zinc oxide — 25 mg/1Manganese sulfate — 2.3 mg/1Ferrous fumarate — 27 mg/1Magnesium oxide — 200 mg/1Molybdenum — 45 ug/1.alpha.-tocopherol acetate, Dl- — 30 mg/1Cholecalciferol — 20 ug/1Selenium — 55 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- PureTek Corporation
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Analogs/Derivatives (Chemical/Ingredient)Ascorbic Acid (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Decreased Copper Ion Absorption (Physiologic effect)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Magnetic Resonance Contrast Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Vitamin A (Chemical structure)Vitamin B 12 (Chemical structure)Vitamin B 6 (Chemical/Ingredient)Vitamin D (Chemical structure)
- Identifiers
- Product ID 59088-168_f204b6b0-92ad-3c22-e053-2995a90ad0aaSPL ID f204b6b0-92ad-3c22-e053-2995a90ad0aaSPL set ID b3637def-a701-673a-e053-2995a90a02d5UNII A150AY412V, 935E97BOY8, 3LE3D9D6OY, TLM2976OFR, 25X51I8RD4, 68Y4CF58BV, P6YC3EG204, H0G9379FGK, PQ6CK8PD0R, 8K0I04919X, SOI2LOH54Z, W00LYS4T26, R5L488RY0Q, 3A3U0GI71G, 81AH48963U, WR1WPI7EW8, 1C6V77QF41, H6241UJ22BUPC 0359088168547
- Pharmacologic class
- Blood Coagulation Factor; Calculi Dissolution Agent; Copper Absorption Inhibitor; Osmotic Laxative; Paramagnetic Contrast Agent; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N459088016854followed by a unit qualifier and the quantityPackage 59088-0168-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS: Vitrexate FE is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.Also for the treatment of a condition in which iron deficiency and vitamin C deficiency occur together, along with a deficient intake or increased need for B-Complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence.
Excerpt only. Read the full label for complete information.